glp-1 receptor agonists and cancer risk in adults with obesity Among #obesity, use of #GLP-1 was associated with reduced of developing several #cancers, including #endometrial, #ovarian, meningioma, compared with those not Frontiers | GLP−1 receptor agonists

The efficacy and safety of tirzepatide, with a special focus on cardiovascular safety, were investigated in the 52-week SURPASS-4 trial testing tirzepatide versus insulin glargine in adults with T2D and a high cardiovascular risk under inadequate glycemic control at baseline on one to three oral glucose-lowering medications (metformin, sulfonylurea, SGLT-2 inhibitor) (74)

A 2.5 mg semaglutide vial with 2.5 mL of bacteriostatic water makes 1 mg/mL, where 0.5 mg draws 50 units and 1 mg draws 100 units

Fast Australian dispatch most orders ship within 2448 hours

TIER PLANS TIER 1 (6mg total) $275 total for 8-10 week supply Monthly cost breakdown: $110-$137 based on weekly dose Recommended if new to treatment or for those on 0.2-0.7mg/week TIER 2 (16mg total) $345 total for 8-10 week supply Monthly cost breakdown: $138-$172 based on weekly dose Recommended for those on 0.8-2mg/week TIER 3 (20mg total) $380 total for 8-10 week supply Monthly cost breakdown: $152-$190 based on weekly dose Recommended for those on 2mg/week and up Boudreaux Pharmacy - Semaglutide/Glycine Injection (NEW) Up to 90 days BUD